Bioventix PLC (FRA:51B)

Bioventix Statistics

Total Valuation

Bioventix has a market cap or net worth of EUR 111.62 million. The enterprise value is 105.75 million.

Market Cap	111.62M
Enterprise Value	105.75M

Important Dates

The next estimated earnings date is Wednesday, March 25, 2026.

Earnings Date	Mar 25, 2026
Ex-Dividend Date	Nov 6, 2025

Share Statistics

Current Share Class	5.22M
Shares Outstanding	n/a
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	-0.15%
Owned by Insiders (%)	6.11%
Owned by Institutions (%)	68.21%
Float	4.15M

Valuation Ratios

The trailing PE ratio is 12.61 and the forward PE ratio is 13.42.

PE Ratio	12.61
Forward PE	13.42
PS Ratio	7.29
PB Ratio	8.28
P/TBV Ratio	8.28
P/FCF Ratio	13.64
P/OCF Ratio	13.61
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.01, with an EV/FCF ratio of 12.93.

EV / Earnings	11.95
EV / Sales	6.98
EV / EBITDA	9.01
EV / EBIT	9.09
EV / FCF	12.93

Financial Position

The company has a current ratio of 9.17

Current Ratio	9.17
Quick Ratio	4.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 64.40% and return on invested capital (ROIC) is 116.92%.

Return on Equity (ROE)	64.40%
Return on Assets (ROA)	47.35%
Return on Invested Capital (ROIC)	116.92%
Return on Capital Employed (ROCE)	87.20%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.28M
Profits Per Employee	737,333
Employee Count	12
Asset Turnover	0.99
Inventory Turnover	1.84

Taxes

In the past 12 months, Bioventix has paid 2.93 million in taxes.

Income Tax	2.93M
Effective Tax Rate	24.88%

Stock Price Statistics

The stock price has decreased by -43.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-43.85%
50-Day Moving Average	20.54
200-Day Moving Average	26.73
Relative Strength Index (RSI)	53.46
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioventix had revenue of EUR 15.30 million and earned 8.85 million in profits. Earnings per share was 1.67.

Revenue	15.30M
Gross Profit	13.90M
Operating Income	11.75M
Pretax Income	11.78M
Net Income	8.85M
EBITDA	11.86M
EBIT	11.75M
Earnings Per Share (EPS)	1.67

Balance Sheet

The company has 5.93 million in cash and n/a in debt, with a net cash position of 5.93 million.

Cash & Cash Equivalents	5.93M
Total Debt	n/a
Net Cash	5.93M
Net Cash Per Share	n/a
Equity (Book Value)	13.48M
Book Value Per Share	2.58
Working Capital	12.51M

Cash Flow

In the last 12 months, operating cash flow was 8.20 million and capital expenditures -22,386, giving a free cash flow of 8.18 million.

Operating Cash Flow	8.20M
Capital Expenditures	-22,386
Free Cash Flow	8.18M
FCF Per Share	n/a

Margins

Gross margin is 90.86%, with operating and profit margins of 76.80% and 57.83%.

Gross Margin	90.86%
Operating Margin	76.80%
Pretax Margin	76.97%
Profit Margin	57.83%
EBITDA Margin	77.51%
EBIT Margin	76.80%
FCF Margin	53.47%

Dividends & Yields

This stock pays an annual dividend of 1.72, which amounts to a dividend yield of 8.18%.

Dividend Per Share	1.72
Dividend Yield	8.18%
Dividend Growth (YoY)	-6.51%
Years of Dividend Growth	n/a
Payout Ratio	108.05%
Buyback Yield	0.08%
Shareholder Yield	8.26%
Earnings Yield	7.93%
FCF Yield	7.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bioventix has an Altman Z-Score of 86.73 and a Piotroski F-Score of 4.

Altman Z-Score	86.73
Piotroski F-Score	4